Tonira Pharma Ltd(merged)
- Market Cap ₹ Cr.
- Current Price ₹ 19.8
- High / Low ₹ /
- Stock P/E
- Book Value ₹
- Dividend Yield 0.00 %
- ROCE 2.07 %
- ROE -15.4 %
- Face Value ₹ 10.0
Pros
- Debtor days have improved from 64.2 to 46.3 days.
Cons
- Company has low interest coverage ratio.
- The company has delivered a poor sales growth of 0.12% over past five years.
- Company has a low return on equity of 1.45% over last 3 years.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Quarterly Results
Standalone Figures in Rs. Crores / View Consolidated
| Operating Profit |
| OPM % |
| Interest |
| Depreciation |
| Profit before tax |
| Tax % |
| EPS in Rs |
| Raw PDF |
Profit & Loss
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2006 | Mar 2007 | Mar 2008 | Mar 2009 | Mar 2010 | Mar 2011 | |
|---|---|---|---|---|---|---|
| 29.86 | 36.55 | 28.61 | 38.47 | 36.82 | 30.04 | |
| 23.59 | 29.67 | 29.55 | 30.18 | 29.97 | 26.31 | |
| Operating Profit | 6.27 | 6.88 | -0.94 | 8.29 | 6.85 | 3.73 |
| OPM % | 21.00% | 18.82% | -3.29% | 21.55% | 18.60% | 12.42% |
| 0.10 | 0.20 | -3.37 | -2.24 | 0.21 | 0.28 | |
| Interest | 1.25 | 1.81 | 2.10 | 3.60 | 2.88 | 3.14 |
| Depreciation | 2.44 | 2.57 | 2.77 | 2.80 | 2.84 | 3.07 |
| Profit before tax | 2.68 | 2.70 | -9.18 | -0.35 | 1.34 | -2.20 |
| Tax % | 35.82% | 39.26% | -36.49% | 111.43% | 23.88% | -5.45% |
| 1.72 | 1.64 | -5.83 | -0.74 | 1.02 | -2.08 | |
| EPS in Rs | ||||||
| Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | 0% |
| 3 Years: | 2% |
| TTM: | -18% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | -3% |
| TTM: | -300% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| 1 Year: | % |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | 0% |
| 3 Years: | 1% |
| Last Year: | -15% |
Balance Sheet
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2006 | Mar 2007 | Mar 2008 | Mar 2009 | Mar 2010 | Mar 2011 | |
|---|---|---|---|---|---|---|
| Equity Capital | 7.94 | 7.94 | 7.94 | 7.94 | 7.94 | 7.94 |
| Reserves | 10.49 | 12.13 | 6.30 | 5.25 | 6.39 | 4.31 |
| 21.41 | 19.68 | 28.91 | 28.38 | 31.30 | 36.74 | |
| 6.10 | 10.13 | 8.97 | 11.47 | 8.06 | 6.62 | |
| Total Liabilities | 45.94 | 49.88 | 52.12 | 53.04 | 53.69 | 55.61 |
| 27.30 | 27.79 | 26.21 | 24.13 | 24.55 | 23.41 | |
| CWIP | 0.00 | 0.00 | 0.11 | 0.09 | 0.54 | 1.21 |
| Investments | 0.12 | 0.04 | 0.04 | 0.04 | 0.14 | 0.14 |
| 18.52 | 22.05 | 25.76 | 28.78 | 28.46 | 30.85 | |
| Total Assets | 45.94 | 49.88 | 52.12 | 53.04 | 53.69 | 55.61 |
Cash Flows
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2006 | Mar 2007 | Mar 2008 | Mar 2009 | Mar 2010 | Mar 2011 | |
|---|---|---|---|---|---|---|
| -0.57 | 5.07 | -4.71 | 3.81 | 7.45 | -0.93 | |
| -5.62 | -3.27 | -1.17 | -0.72 | -3.82 | -2.63 | |
| 6.11 | -1.72 | 7.10 | -4.12 | -1.10 | 2.70 | |
| Net Cash Flow | -0.08 | 0.08 | 1.22 | -1.03 | 2.53 | -0.86 |
Ratios
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2006 | Mar 2007 | Mar 2008 | Mar 2009 | Mar 2010 | Mar 2011 | |
|---|---|---|---|---|---|---|
| Debtor Days | 68.09 | 40.24 | 69.15 | 83.49 | 62.75 | 46.29 |
| Inventory Days | 316.06 | 345.49 | 248.07 | 256.28 | 233.19 | 360.14 |
| Days Payable | 120.00 | 137.70 | 142.47 | 179.57 | 129.62 | 118.73 |
| Cash Conversion Cycle | 264.15 | 248.04 | 174.74 | 160.20 | 166.33 | 287.70 |
| Working Capital Days | 158.30 | 130.42 | 172.61 | 147.54 | 164.36 | 256.86 |
| ROCE % | 11.36% | -7.60% | 14.09% | 9.68% | 2.07% |
Documents
Announcements
No data available.